Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma.
Glas
Martin
M
Hennemann
Burkhard
B
Hirschmann
Birgit
B
Marienhagen
Jörg
J
Schmidt-Wolf
Ingo
I
Herrlinger
Ulrich
U
Bogdahn
Ulrich
U
Hau
Peter
P
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D020295:Brain Stem Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D002528:Cerebellar Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D005260:Female; D006423:Hemianopsia / Q000209:etiology; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008527:Medulloblastoma / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000556:secondary*; D015282:Octreotide / Q000627:therapeutic use*; D019574:Optic Nerve Neoplasms / Q000188:drug therapy / Q000556:secondary*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000209:etiology; D018714:Radiotherapy, Adjuvant; D017481:Receptors, Somatostatin / Q000032:analysis; D016879:Salvage Therapy; D013004:Somatostatin; D014750:Vincristine / Q000008:administration & dosage
D018931:Antineoplastic Agents, Hormonal; D017481:Receptors, Somatostatin; D013004:Somatostatin; D014750:Vincristine; D008130:Lomustine; D002945:Cisplatin; D015282:Octreotide